2825 related articles for article (PubMed ID: 7703717)
1. A receptor for VIP-related peptides with an unusual selectivity profile on the melanoma cell line IGR37.
Fabre C; Bellan C; Marvaldi J; Luis J
Melanoma Res; 1994 Dec; 4(6):379-83. PubMed ID: 7703717
[TBL] [Abstract][Full Text] [Related]
2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
3. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
4. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
5. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
6. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
10. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
11. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
12. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
Shima K; Sakakibara H; Said SI
Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
[TBL] [Abstract][Full Text] [Related]
14. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
Chijiiwa Y; Murthy KS; Grider JR; Makhlouf GM
Regul Pept; 1993 Sep; 47(3):223-32. PubMed ID: 8234906
[TBL] [Abstract][Full Text] [Related]
15. Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP.
Du K; Nicole P; Couvineau A; Laburthe M
Ann N Y Acad Sci; 1998 Dec; 865():386-9. PubMed ID: 9928035
[No Abstract] [Full Text] [Related]
16. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.
Gaudin P; Couvineau A; Maoret JJ; Rouyer-Fessard C; Laburthe M
Eur J Pharmacol; 1996 Apr; 302(1-3):207-14. PubMed ID: 8791009
[TBL] [Abstract][Full Text] [Related]
18. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
19. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J
Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
[TBL] [Abstract][Full Text] [Related]
20. Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines.
Luis J; Said SI
Peptides; 1990; 11(6):1239-44. PubMed ID: 1965034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
